VASC Financial Facts

Income tax expense: -1.19M
Cost of goods sold: 9.72M
See Full Income Statement

Accrued compensation: 4.37M
Current portion of deferred tax assets: -14.4M
See Full Balance Sheet

Vascular Solutions (VASC) Earnings

  |   Expand Research on VASC
Next EPS Date 7/23/14 *Est. EPS Growth Rate 0.0% *Last Qtr.
Average EPS % Beat Rate +48.5% Revenue Growth Rate +14.6% *Last Qtr.
Average % Move 1-Wk after EPS -0.4% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. % Since Details
4/22/14 Q114 $0.16N/A N/A $29.9M$26.1M 0% Details
2/4/14 Q413 $0.22$0.19 +$0.03$29.1M$28.61M +2.8% Details
10/22/13 Q313 $0.19$0.07 +$0.12$28M$27.1M 0% Details
7/23/13 Q213 $0.17$0.17 $0.00$27.4M$27M +50.1% Details
4/23/13 Q113 $0.16$0.15 +$0.01$26.1M$26.51M +47.1% Details
2/5/13 Q412 $0.18$0.17 +$0.01$25.3M$25.59M +46.8% Details
10/18/12 Q312 $0.16$0.15 +$0.01$24.6M$24.77M = +66.6% Details
7/24/12 Q212 $0.15$0.13 +$0.02$24.7M$24.15M +92.9% Details